CARE Ratings Gears Up for Q3 Reveal on 11th February; Check Key Expectations Here

February 10, 2026
Posted by: Ekta Dhawan
Category: News

Click and Sign Up to Get Live Updates on Q3 Results

CARE Ratings ‘s Q3 results FY26 are scheduled to be announced on 11th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Table of Contents

CARE Ratings Q3 Results 2026 Preview

CARE Ratings’ revenue is expected to be in the range of ₹96.38 crore, a 17.88% YoY decrease.
Profit After Tax, or PAT, is projected to fall 39.67% YoY.
Net profit is ₹27.80 crore, up 39.67% YoY
EBITDA to fall 48.12%

CARE Ratings Share Performance

Over the past six months, CARE Ratings’ share price has fallen by 3.49% to ₹1,616.20.
Moreover, over the past year, the stock has increased by 29.20%.
Despite this weak short-term performance, CARE Ratings’ stock has delivered a financially sound 235.21% return over the past 5 years.
As of 10th February 2026, the stock traded at ₹1,616.20 per share.

About CARE Ratings

CARE Ratings Limited is one of India’s leading credit rating agencies, established in 1993 and headquartered in Mumbai. It provides independent credit ratings and analytical services for a wide range of financial instruments, including bonds, bank loans, commercial papers, and structured finance products.

Key Factors to Watch for CARE Ratings Q3 Results FY26

Revenue Growth: Performance of core ratings and analytics business driven by debt market activity.
Profitability & Margins: Trends in EBITDA and PAT margins reflecting operating efficiency and cost control.
Ratings Volume & Market Activity: Growth in new ratings, renewals, and corporate borrowing/issuance levels.
Non-Ratings Income: Contribution from ESG, research, analytics, and advisory services.
Cost Structure: Movement in employee and technology expenses impacting margins.

Final Thoughts

CARE Ratings will announce its Q3 FY26 results on 11th February 2026. Analysts expect 17.88% revenue growth, a 39.67% fall in PAT, and a 48.12% fall in EBITDA. CARE Ratings focuses on revenue growth from order execution, margin improvement, the strength of order book, and management outlook on digital infrastructure demand.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Alfred Herbert India Ltd Q3 Results FY26 Preview: PAT falls 3%

Salora International Q3 Results FY26 Preview: PAT falls 18.54%

Kuantum Papers Q3 Results FY26 Preview: PAT falls 29.85%

AK Capital Services Ltd Q3 Results FY26 Preview: PAT falls 16.86%

Glance Finance Q3 Results FY26 Preview: PAT rises 58.48%

Q3 Results Q3 Results 2026

Author: Ekta Dhawan

Ekta Dhawan is a Financial Content Writer at Univest, covering Indian equity markets with a focus on stock analysis, IPOs, and quarterly earnings results. Over 2+ years, she has published 1500+ articles tracking listed companies across sectors, translating complex financial data into clear, actionable insights for retail investors. She holds a Bachelor of Business Administration (BBA) and a Post Graduate Diploma in Management (PGDM), giving her a structured grounding in corporate finance, equity valuation, and capital markets. Her writing moves past surface-level reporting to explain why a stock is moving, what a quarterly result signals, and how investors should interpret it. She also brings expertise in SEO content strategy, keyword research, and on-page optimisation, ensuring articles reach investors actively searching for clarity on market events. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.